Ever since the second world symposium on pulmonary hypertension (PH) held in Evian,
France, in 1998, PH has been classified into five major clinical groups. Group 5 PH includes …

Pulmonary hypertension (PH) is a clinical condition characterized by increased pulmonary
arterial pressure arising from a heterogeneous range of diseases that has a deteriorating …

Rationale: Precapillary pulmonary hypertension (PH) is a rare and largely unrecognized
complication of myeloproliferative neoplasms (MPNs), including polycythemia vera (PV) …

Abstract Background and aims The Tracking Outcomes and Practice in Pediatric Pulmonary
Hypertension (TOPP) registry is a global network established to gain insights into the …

Abstract Purpose of the Review Tricuspid regurgitation is associated with increased mortality
in proportion to right ventricular adaptation to increased volume loading and pulmonary …

The main aim of this analysis was to investigate time from symptom onset (chronic
unexplained dyspnoea [CUD]) to diagnosis of Group 1 pulmonary hypertension (PH) …

BACKGROUND: The precise origin of newly formed ACTA2+ (alpha smooth muscle actin-
positive) cells appearing in nonmuscularized vessels in the context of pulmonary …

Pulmonary arterial hypertension (PAH) is an orphan disease of the cardiopulmonary unit
that reflects an obstructive pulmonary vasculopathy and presents with hypertrophy …

Pulmonary hypertension (PH) is a chronic pulmonary vascular disorder characterized by an
increase in pulmonary vascular resistance and pulmonary arterial pressure. The detailed …

The tricuspid valve is a complex structure with normal function dependent on the leaflet
morphology, right atrial and annular dynamics, and right ventricular and chordal support …